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Background: Canine GM1 gangliosidosis is a fatal disease in the Shiba Inu breed, which is one of the most popular
traditional breeds in Japan and is maintained as a standard breed in many countries. Therefore, it is important to
control and reduce the prevalence of GM1 gangliosidosis for maintaining the quality of this breed and to ensure
supply of healthy dogs to prospective breeders and owners. This molecular epidemiological survey was performed
to formulate an effective strategy for the control and prevention of this disease.
Results: The survey was carried out among 590 clinically unaffected Shiba Inu dogs from the 8 districts of Japan,
and a genotyping test was used to determine nation-wide and regional carrier frequencies. The number and native
district of affected dogs identified in 16 years from 1997 to June 2013 were also surveyed retrospectively. Of the
590 dogs examined, 6 dogs (1.02%, 6/590) were carriers: 3 dogs (2.27%, 3/132) from the Kinki district and the other
3 dogs from the Hokkaido, Kanto, and Shikoku districts. The retrospective survey revealed 23 affected dogs, among
which, 19 dogs (82.6%) were born within the last 7 years. Of the 23 affected dogs, 12 dogs (52.2%) were from the
Kinki district. Pedigree analysis demonstrated that all the affected dogs and carriers with the pedigree information
have a close blood relationship.
Conclusions: Our results showed that the current carrier frequency for GM1 gangliosidosis is on the average 1.02%
in Japan and rather high in the Kinki district, which may be related to the high prevalence observed over the past
16 years in this region. This observation suggests that carrier dogs are distributed all over Japan; however, kennels
in the Kinki district may face an increased risk of GM1 gangliosidosis. Therefore, for effective control and prevention
of this disease, it is necessary to examine as many breeding dogs as possible from all regions of Japan, especially
from kennels located in areas with high prevalence and carrier frequency.
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GM1 gangliosidosis, a lysosomal storage disease that af-
fects the brain and multiple systemic organs, is caused
by an autosomal recessively inherited deficiency in acid
β-galactosidase, which is encoded by the GLB1 gene [1].
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reproduction in any medium, provided the orin 2000 [2]. The causative mutation has been identified
as a deletion of the cytosine in exon 15 at nucleotide
position 1647 in the putative coding region (c.1647delC)
of the canine GLB1 gene [3], thereby enabling molecular
diagnosis and/or genotyping with polymerase chain reac-
tion (PCR)-based DNA tests [4,5]. Affected dogs mani-
fest neurological signs of progressive motor dysfunction
from 5–6 months of age and die at 12–18 months after
a clearly defined clinical course [6,7], which is associated
with progressive accumulation of GM1 ganglioside andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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system [2,6,8].
The Shiba Inu breed is indigenous to and one of the
most popular breeds in Japan, where it has been desig-
nated as a protected species since 1936 (http://www.
nihonken-hozonkai.or.jp/). Thirty to forty thousand pup-
pies are registered every year in Japan [9]. Shiba Inu
dogs have been transported worldwide and are bred
and maintained as a standard breed in many coun-
tries. Therefore, it is necessary to control and reduce
the prevalence of GM1 gangliosidosis to maintain the
quality of this traditional breed and to ensure supply
of healthy dogs to prospective breeders and owners
in Japan and other countries.
Previously, a preliminary genotyping survey of the dis-
ease was carried out on 68 Shiba Inu dogs from only the
Hokkaido and the Tohoku districts (Figure 1) in north-
ern Japan [9]. This survey revealed 2 carriers among the
68 dogs. Although, carriers appear to be distributed all
over Japan, specific areas and kennels may show high
prevalence. Therefore, a large-scale and nationwide sur-
vey is necessary to know the current overall and regional
prevalence and carrier frequency in Japan, as well as to
formulate an effective strategy for the control and pre-
vention of this disease.
In the present study, a large-scale molecular epidemio-
logical survey of GM1 gangliosidosis in the Shiba InuFigure 1 Map of Japan showing the districts surveyed in the
present study. Bold lines show district boundaries on the main
island, and dashed lines show prefectural boundaries.breed was carried out among 590 dogs from all the dis-
tricts of Japan by using a genotyping test to determine
the current overall and regional carrier frequency. The
number and native district of affected dogs identified
in 16 years from 1997 to June 2013 were also surveyed
retrospectively. The pathway of transmission and distri-
bution of the mutant allele were analyzed on the basis of
pedigree information of the affected dogs and carriers
identified previously and in this study. In this report, we
also discuss the control and prevention of the disease on
the basis of the results of these analyses.
Results
Carrier frequency
The results of the nationwide molecular epidemiological
survey are shown in Table 1. This survey revealed 584
wild-type dogs, 6 carriers, and no affected dogs in the
population of 590 animals. The carrier frequency in the
population was 1.02%. Among the 6 carriers identified, 3
dogs were from the Kinki district and the other 3 dogs
were from the Hokkaido, Kanto, and Shikoku districts.
Retrospective survey and pedigree analysis
The retrospective survey conducted using information
collected over 16 years from 1997 to 2013 revealed 23
affected dogs (A1–A23) and several carriers that were
related to these affected dogs. The first affected dog
(A1-H), born in the Hokkaido district in 1997, was diag-
nosed with GM1 gangliosidosis histopathologically and
biochemically [2], which was confirmed by molecular
analysis using stored DNA and RNA [3]. Since this case,
other affected dogs with the same molecular defect have
been diagnosed sporadically until recently (Figure 2). Of
the 23 affected dogs identified, 19 dogs were born within
the last 7 years. The pedigree relationships among these
affected dogs and the native district of each dog areTable 1 Results of the nationwide genotyping survey of
GM1 gangliosidosis in Shiba Inu dogs in Japan
District Examined dogs Genotypes
Wild-type Carrier
Hokkaido 23 22 1
Tohoku 17 17 0
Kanto 227 226 1
Chubu 135 135 0
Kinki 132 129 3
Chugoku 9 9 0
Shikoku 2 1 1
Kyushu* 42 42 0
Unknown 3 3 0
Total 590 584 6
* Including Okinawa prefecture, the small islands south of Kyushu Island.
Figure 2 Change in the number of Shiba Inu dogs with GM1 gangliosidosis from 1997 to 2012. The 23 affected dogs (A1–A23) were
plotted in the order in which they were born.
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available for 5 affected dogs, the remaining 18 affected
dogs and several related carriers identified previously
showed a blood relationship, according to the results of
the pedigree analysis. Regarding the native districts, 12
affected dogs were from the Kinki region, accounting for
approximately half of all the affected animals.
A pedigree analysis was also performed using the data
from 2 carriers (C1-Ka and C2-Ki) identified in the present
epidemiological survey. No pedigree data was available for
the 4 remaining carriers. C1-Ka and C2-Ki also showed a
blood relationship with the affected dogs and carriers iden-
tified in the retrospective survey (Figure 3).Figure 3 The pedigree of Shiba Inu dogs with GM1 gangliosidosis. Th
Chugoku (Cg), Kanto (Ka), Shikoku (S), and Kyushu (Ky) districts. Pedigree
A18, and A21). Two carriers (C1-Ka and C2-Ki) were identified in the Kan
survey of this study. * Carriers from a specific kennel, which are relatedDiscussion
Recessively inherited disorders such as lysosomal storage
diseases are a major problem in the breeding of pure-
breed domestic animals [9-11]. Identification of the car-
riers that have one abnormal allele in the gene pair, but
that are normal in clinical appearance, is critical because
there are no physical clues to the presence of the disease
in these animals; however, the mutation is transmitted to
half of their progeny [11]. The frequency of carriers in a
population substantially exceeds the incidence of the dis-
ease; therefore, the presence of carriers makes recessive
diseases the most difficult to control in pure-breed
animals [11,12]. Canine GM1 gangliosidosis has beene 23 affected dogs (A1–A23) are from the Hokkaido (H), Kinki (Ki),
information was not available for 5 affected dogs (A9, A10, A17,
to and Kinki districts, respectively, in the molecular epidemiological
to a number of affected and carrier offspring in the Kinki district.
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Springer Spaniels [13], Portuguese Water Dogs [14],
and Alaskan Huskies [15]; however, to the best of our
knowledge, a large-scale molecular epidemiological sur-
vey has not been performed to establish effective mea-
sures for the control and prevention of the disease.
Our results demonstrated that the overall carrier fre-
quency of GM1 gangliosidosis among Shiba Inu dogs
in Japan is 1.02% (6/590). In this study, regional data
for northern (i.e., Hokkaido and Tohoku districts) and
western or southern Japan (i.e., Chugoku, Shikoku, and
Kyushu districts) were not fully evaluated because of
the low number of samples collected from these re-
gions. Among the districts sufficiently surveyed by a
large number of samples, Kinki had the highest carrier
frequency (2.27%, 3/132), which is more than 5 times
that in Kanto (0.44%, 1/227). As the number of carriers
is small, the calculated frequency could potentially be
changed dramatically by chance. Specific families that
include carriers may have also affected the frequency
(i.e., population stratification). Therefore, the limitation
of this study is that the calculated disease prevalence and
carrier frequency may be influenced by chance.
In the retrospective survey, in the last 16 years, 23 af-
fected dogs were identified, and 19 dogs of these were
born within the last 7 years (Figure 2), suggesting a re-
cent increase in the prevalence of the disease. Of the 23
affected dogs identified, 12 dogs were from the Kinki
district. Of the 19 affected dogs identified in the last 7
years, 11 dogs were from the Kinki district, suggesting a
recent increase in the prevalence in Japan, probably due
to the high incidence of affected dogs in the Kinki dis-
trict. The high incidence of affected dogs in the Kinki
district seems to be attributable to a small number of
popular carrier sires (shown by an asterisk in Figure 3)
in the same region.
There are 8 district affiliates in Nihon-ken Hozon-kai,
a major kennel club specializing in Japanese traditional
breeds (http://www.nihonken-hozonkai.or.jp/). Further-
more, each district affiliate has several regional branch
divisions with many kennels. Most kennels are small
with only a few breeding dogs. Regional activities such
as local dog-shows are carried out in each branch div-
ision before the district and nationwide activities. There-
fore, there is a strong relationship among the kennels
belonging to the same branch division. Mating also
tends to be among dogs in the same branch division,
resulting in potential inbreeding and homozygosity
responsible for inherited disorders.
In the present study, a kennel with a very high preva-
lence of the disease was found in the Kinki district by
pedigree analysis. This kennel housed 2 carriers, who
were divisional champion dogs (shown by an asterisk in
Figure 3), which produced many of the affected andcarrier offspring in the Kinki district. Such kennels may
be producing affected dogs sporadically by unknowingly
mating carriers. It is thought that affected dogs are pro-
duced in a small proportion of kennels with high preva-
lence, and the mutant allele is then distributed to the
surrounding areas from those kennels. This may be the
reason behind the relationship between regional preva-
lence and carrier frequency in GM1 gangliosidosis in
Shiba Inu dogs. A similar trend was observed in a survey
of neuronal ceroid lipofuscinosis in the Border Collie
breed in Japan [16]. Therefore, for the effective control
and prevention of these fatal inherited diseases, it is ne-
cessary to examine as many breeding dogs as possible,
especially from kennels located in areas with high preva-
lence and carrier frequency. In addition, genotyping of
specimens from a random population of breeding dogs
should be continued to detect sporadic carriers and pre-
vent their use from being used as breeding dogs [12].
These approaches will also gradually decrease the num-
ber of dogs carrying the mutant allele. These active and
continuous preventive measures may be necessary to
eliminate GM1 gangliosidosis in Shiba Inu dogs.
Conclusions
Based on the results of the present study, the current
carrier frequency for GM1 gangliosidosis in the overall
Shiba Inu dog population in Japan is 1.02%, and it is ra-
ther high (2.27%) in the Kinki district. The high carrier
frequency in the Kinki region seems to be related to the
high prevalence in this district. Therefore, for the effect-
ive control and prevention of this disease, it is necessary
to examine as many breeding dogs as possible from all
regions of Japan, especially from kennels located in areas
with high prevalence and carrier frequency.
Methods
Sample collection and genotyping
Blood samples were collected randomly from 590 client-
owned Shiba Inu-breed dogs with the cooperation of their
owners and veterinarians from different animal hospitals
in Japan. These dogs were clinically unaffected for GM1
gangliosidosis. The dogs were native to the Japanese dis-
tricts shown in Table 1 and Figure 1. The genotypes of
the dogs were determined using real-time PCR as previ-
ously reported [4].
Retrospective survey and pedigree analysis
The number and the native district of the affected dogs
were surveyed retrospectively based on the records in
our laboratory, which has been exclusively supporting
the diagnosis of this disease in Japan. Pedigree analysis
was performed to elucidate the genetic relationships
among the affected dogs and carriers identified previ-
ously and in the present study, as well as to deduce the
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allele. The genetic relationships among the affected dogs
and carriers were analyzed using the pedigree records is-
sued by the Nihon-ken Hozon-kai (http://www.nihonken-
hozonkai.or.jp/) and the Japan Kennel Club (http://www.
jkc.or.jp/), a kennel club certified by the Federation
Cynologique Internationale (http://www.fci.be/).
All the experimental procedures using animals and
their specimens were performed in accordance with
the guidelines regulating animal use and ethics issued
by the Experimental Animals Committee at Kagoshima
University.
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